You can set your preferences for social media and targeted advertising cookies here. We always place functional cookies and analytical cookies. Functional cookies are necessary for the site to work properly. With analytical cookies we collect anonymous data about the use of our site. With that information, the site can be further improved so that it is easier for you to find what you are looking for.
Through state-of-the art research, we aim to identify biological systems to promote healthy aging and/or treat human disease of the central nervous system.
The research mission of the section Molecular Neurobiology is to study the molecular and cellular processes and overall function of the central nervous system (CNS) during development, healthy ageing and CNS diseases. Through state of the art techniques and approaches we aim to identify novel targets to promote healthy aging, to delineate disease aetiology and to modulate progression.
In the context of the central theme Healthy Ageing of the University of Groningen, the interrelated fields of interest of the section are neurophysiology and neuroimmunology. CNS ageing and inflammatory neurodegeneration are central topics. These processes are mainly studied in the context of neurodegenerative diseases like Alzheimer’s disease and multiple sclerosis (MS):
we study several aspects of molecular neurobiology including (epi)genetics, neuron-glia interactions and functions, and CNS physiology. Model systems include mammalian cells, mice, (patient-derived) induced pluripotent stem cells (iPSCs), organoids, and organotypic slice models and human CNS tissue;
diseases studied focus on neurodevelopmental, neurodegenerative and neuroinflammatory disorders, i.e. Alzheimer’s disease, multiple sclerosis, frontotemporal dementia and psychiatric disorders.
Relevance
How our research benefits to society
Our research impacts our society by the potential development and identification of novel intervention strategies to treat diseases that affect the human CNS by increasing our fundamental knowledge of the underlying neurobiological processes.
Environmental factors in combination with hereditary or acquired gene mutations can lead to severe human CNS pathologies. The interaction between these environmental factors and the genetic risk conveyed by these gene mutations is not always known, and their causality to CNS disease is poorly understood. Unveiling their effect on molecular, cellular and CNS tissue functions and physiology is essential to identify potential targets and to develop therapeutic interventions:
molecular causes and the pathophysiology of human CNS disease;
therapeutic targets and treatment strategies for human CNS disease;
biomarkers and assays to monitor the development of human diseases;
fundamental biological and medical knowledge;
technological innovation in life sciences and medicine.